Robert J. Lee

This researcher's publication record focuses on drug delivery systems, particularly nanoparticle- and liposome-based carriers (such as polymeric micelles and immunoliposomes) designed to improve the delivery of cancer drugs like paclitaxel and rapamycin. Other work touches on inflammation-related conditions such as ulcerative colitis and atherosclerosis, as well as more recent studies on taste receptor agonists in head and neck cancer cells. The overall body of work sits at the intersection of pharmaceutical formulation, nanomedicine, and cancer/inflammation biology.

Publication output has been sparse and irregular over the last decade, with several years showing no recorded output, though there is a small uptick in 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026